{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-026623","form_type":"8-K","ticker":null,"cik":"0001460602","company_name":"Orgenesis Inc.","filed_at":"2024-07-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.116825+00:00","generated_at":"2026-05-31T22:34:13.892065+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Orgenesis director resigns, Itzhak Vider appointed to board and audit committee","bullets":["Curtis Slipman resigned as director effective July 3, 2024, for personal reasons; no disagreement with company.","Dr. Itzhak Vider appointed to board and Audit Committee effective July 8, 2024, filling the vacancy.","Vider granted initial option for 6,250 shares at $0.65 exercise price, vesting over three years.","Vider receives $40,000 annual cash retainer plus annual option for 12,500 shares under director compensation policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-026623","json":"https://secwatch.observer/filing/0001493152-24-026623.json","markdown":"https://secwatch.observer/filing/0001493152-24-026623.md","text":"https://secwatch.observer/filing/0001493152-24-026623.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224026623/0001493152-24-026623-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224026623/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:34:13.892065+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9a4bdfd0d9","claim":"Curtis Slipman resigned as director at Orgenesis Inc..","evidence_excerpt":"On July 3, 2024, Curtis Slipman notified Orgenesis Inc. (the “Company”), of his decision to resign as a director of the Company, effective immediately, for personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224026623/0001493152-24-026623-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"a394f47efb","claim":"Itzhak Vider was appointed as director at Orgenesis Inc..","evidence_excerpt":"On July 8, 2024, the board of directors of the Company (the “Board”), upon the recommendation of the Nominating Committee of the Board, appointed Dr. Itzhak Vider as a director, effective July 8, 2024, to fill the vacancy on the Board created by Mr. Slipman’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315224026623/0001493152-24-026623-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}